SCHEMBL31024345

SCHEMBL31024345

CN(C)CCc1c[nH]c2cccc(OC(=O)OCCC[Si](C)(C)C)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.56
HTR2A P28223 10/20 0.55
HTR2C P28335 6/20 0.55
HTR2B P41595 6/20 0.55
HTR1A P08908 6/20 0.55
HTR1B P28222 4/20 0.49
HTR1D P28221 3/20 0.49
HTR7 P34969 2/20 0.49
HTR5A P47898 2/20 0.49
DRD1 P21728 1/20 0.49
HTR1E P28566 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA2B P29275 1/20 0.49
DRD3 P35462 1/20 0.49
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
HTR1F P30939 1/20 0.46
SLC6A4 P31645 1/20 0.42
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25790561 0.92 HTR6 (0.62) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL31404490 0.91 HTR6 (0.61) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26323232 0.89 HTR2A (0.63) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26646464 0.88 HTR2A (0.65) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL31024322 0.88 HTR6 (0.60) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL31404488 0.87 HTR6 (0.62) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26307597 0.87 HTR2A (0.66) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL31417453 0.87 HTR2A (0.66) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26323233 0.86 HTR6 (0.61) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26323272 0.85 HTR6 (0.71) HTR6HTR2AHTR2CHTR2BHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655282-A1 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-YL DERIVATIVES COMPASS Pathfinder Limited (GB) 2025-12-03 EP disclosed
US-20240269113-A1 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES COMPASS PATHFINDER LIMITED (GB) 2024-08-15 US disclosed
WO-2024156732-A1 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-YL DERIVATIVES COMPASS PATHFINDER LIMITED (GB) 2024-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240269113-A1 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES HTR2C, HTR2A, HTR1A HTR6 6/4885HTR2A 2/4885HTR2C 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.